After a prolonged downturn lasting nearly four years, the biotechnology industry is showing clear signs of recovery. Taking ...
A new West Coast biotech has emerged into the busy in vivo cell therapy space, this time with the backing of Nobel Prize-winning CRISPR pioneer Jennifer Doudna, Ph.D. Azalea Therapeutics has bloomed ...
Strategic focus shifted from U.S.-centric growth to global expansion, with launches in Germany, France, and Japan. Analysts’ questions in this quarter were more international and operationally focused ...
When Big Pharma ties its corporate social responsibility initiatives to patients' needs, too often it veers into theater.
Welcome to the Fierce Biotech Graveyard, a yearly ritual where we remember all the biotechs we lost in 2025. While we're ...
America can either cede the future of biotechnology to our adversaries or summon the vision and resolve to lead it.
The U.S. has ceded its leadership in critical industries before. It must not do so with China and biotech now, writes the ...
Still, the recently released 2025-30 Arizona Bioscience Roadmap, as well as several academic, community and local government ...
Barchart on MSN
North Carolina Wants to ‘Lead the Nation’ in Psychedelics. Here’s 1 ‘Strong Buy’ Stock to Buy Now.
Depression remains one of the world’s most debilitating conditions, impacting millions worldwide with symptoms that can ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min There is more research-and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback